Massimiliano Fabbiani is Associate Professor of Infectious Diseases at the Department of Medical Biotechnologies of the University of Siena. His research activity is mainly focused on HIV infection and antiretroviral therapy. In particular, he has participated in clinical trials on antiretroviral therapy and has conducted studies on the efficacy and tolerability of antiretroviral therapy, on the clinical pharmacology of antiretroviral drugs, on the epidemiology and resistance mechanisms of HIV, on adherence to therapy and on comorbidities during HIV infection (with a particular focus on HIV-related neurocognitive disorders). He has also studied the response to vaccinations (anti-influenza, anti-SARS-CoV-2, anti-pneumococcus) in subjects with and without HIV infection. Among the topics covered by his research activities are also infections by hepatitis viruses (HAV, HBV, HCV), SARS-CoV-2 infection, bacterial and fungal infections.
